NXGL NEXGEL, Inc.
USHealthcareAs of 2026-10-09
Why NXGL matters now
NEXGEL, Inc. (NXGL) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.20 with +33.53% on the session and $84.9K in market capitalization; recent performance reads 1-month -7.80% and YTD -64.84%.
The latest financial table shown here is Q1 2026, with revenue of $2.6M, net income of $-927.0K, and EPS of $-0.11. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -27.3%.
The latest indexable market news headline is "NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation Transcript" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Levy Adam R. filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
1.16
P/S
0.46
EV/EBITDA
-4.16
DCF Value
$-263.09
FCF Yield
-27.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.9%
Operating Margin
-31.4%
Net Margin
-28.5%
ROE
-70.2%
ROA
-27.7%
ROIC
-40.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.6M | $-927.0K | $-0.11 |
| Q4 2025 | $2.8M | $-970.0K | $-0.12 |
| FY 2025 | $11.4M | $-3.0M | $-0.38 |
| Q3 2025 | $2.9M | $-653.0K | $-0.08 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
0.74
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.